POA Pharma Scandinavia AB and MERUS LABS INTERNATIONAL INC., expands there existing Promotion & Distribution Agreements for EMSELEX®/ENABLEX® with SALAGEN® for the Nordics.
Toronto/Gothenburg, February 1, 2016 – Merus Labs International Inc. [TSX: MSL, NASDAQ: MSLI] is pleased to announce that through its wholly owned subsidiaries, Merus Labs B.V and Merus Labs Luxco S.à R.L., it has entered into promotion and distribution agreements with POA Pharma Scandinavia AB for the Merus Labs Salagen® product.
POA Pharma Scandinavia AB has been granted exclusive rights to distribute, Salagen® in the Nordics defined collectively as Denmark, Norway, Sweden, Finland, and Iceland.
”Salagen® with its indication,
Severe xerostomia following radiotherapy for cancer of the head and neck area and Symptomatic treatment of dry mouth and dry eyes in patients with Sjögren's syndrome, is a perfect fit for our competence area ENT and we are happy being able to increase our cooperation with and important, exiting and international partner,” says Tina Madsen CEO at POA.
Frank Rotmann, VP & Head of European Operations: ”With our defined strategy utilizing our expertise in pharmaceutical markets in Europe and our access to capital to acquire and license specialty care branded products, it is crucial having a stable partner in the interesting Nordic market.”
Merus Labs International Inc. is a specialty pharmaceutical company engaged in the acquisition and licensing of pharmaceutical products. The Company utilizes its expertise in pharmaceutical markets and its access to capital to acquire and license niche branded products. Merus further enhances the sale and distribution of these products by the introduction of a focused marketing and promotion plan.
POA Pharma Scandinavia. POA is a young Boutique Health care company, 5 years old, with offices in the four Nordic countries and in US. POA stands for Point Of Action, new ideas and new combinations and is occupied within three strategic areas:
1. The Nordics were POA represent 14 Pharmaceutical producers from 11 countries. The products are placed in 9 areas of Competence – therapy sections.
2. Central marketing and development of own products.
3. Export with distribution agreement with close to 40 countries.
The Titan Atlas lost the battle against the gods. As punishment he had to carry the world on his shoulders.
The Know-How area Head & Neck is related to Oral Medicine and Oncology. The area consists of head-, neck- and throat diseases including Meniere’s disease and head and neck problems. The atlas bone, which carries the cranium, is often overlooked as a cause of pain “from top to bottom”. If the atlas bone is out of place, the function of the whole spine is impaired.
Nutrition with medical purposes for specific metabolic indications.
This is one way of describing Metabolic diseases – a competence area that previously was known as dietary treatment. The area is a scientifically based development and prescription of food for the prevention and treatment of metabolic diseases, which if untreated leads to disease and premature death. The subject integrates different scientific disciplines such as biochemistry, molecular biology, physiology, medicine, toxicology, food science, epidemiology and public health science.
”Man is a bowel surrounded by a body”, as somebody once said.
Our digestive organs are the means for our nutritional uptake. Diseases in this big and complex system are common, such as ulcers, gallstone, jaundice, indigestion, and irritable bowel syndrome and tumour diseases. The medical term for the speciality within the digestive system is gastroenterology. It is an area within the scientific discipline of internal medicine.